Phase
Alumni community member
Medetect
Medetect is a full-service contract research organization (CRO) within histology with profound competence in immunopathology, computerized quantitative image analysis and histological research. The company contributes with histology-based research to the pharmaceutical industry, foremost in target assessment and validation projects. Medetect is one of the few CROs offering the combination of cutting-edge histology and image analysis together with scientific and strategic consultancy.
Prof. Jonas Erjefält founded Medetect in 2008 as a spin-off from his academic research at Lund University. At Medetect, he can be consulted in his role as scientific, histological and strategic advisor.
Non-invasive cardiac pressure monitoring device
Accelerated drug development in oncology
Unique stem cell therapeutics
3D cell culture systems
Rapid Diagnostics for Multi-pathogen detection
Individualised information of the intestinal flora
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Pest control solutions for bed bugs
Neonatal Lung Analyzer
Prebiotics for irritable bowel syndrome
Nanotechnology based infection control
Excellence in designing & executing drug discovery
Models for autoimmune & inflammatory conditions
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Male-Factor Infertility Diagnostics
Customized in vitro and in vivo services
Stroke detection device
Wound treatment gel
Regenerative medicine & cancer
